42 Results for "

Itch

" in MedChemExpress (MCE) Product Catalog:
Products (42)

42 Results for "Itch" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P99025
CAS No.: 953400-68-5
Synonyms: TNX-650; MILR1444A; RG3637

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Lebrikizumab (TNX-650) is an IgG4 humanized anti-interleukin-13 (IL-13) mAb with anti-itch effects that specifically binds to IL-13 in a non-receptor binding domain and inhibits its function. Lebrikizumab inhibits the IL-13 driven Th2 inflammatory response and blocks the signaling of IL-4Rα/IL-13Rα1. Lebrikizumab can be used for the research of asthma, atopic dermatitis and neuroinflammatory diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1183
CAS No.: 50-03-3
Synonyms: Hydrocortisone 21-acetate; Cortisol 21-acetate
Hydrocortisone acetate (Hydrocortisone 21-acetate) is a corticosteroid used to reduce swelling, itching and pain caused by minor skin irritations or hemorrhoids .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103368
CAS No.: 461000-66-8
Purity:  98.86%
Target:  

Chloride Channel

Research Areas:  

Neurological Disease

Eact is a selective and potent activator of TMEM16A, directly activates the TRPV1 channels in sensory nociceptors and produces itch, acute nociception and thermal hypersensitivity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-118069
CAS No.: 2089389-15-9
Purity:  99.83%
(R)-ZINC-3573 is a selective Mas-related G protein-coupled receptor X2 (MRGPRX2) agonist with an EC50 value of 740 nM. (R)-ZINC-3573 can be used as a MRGPRX2 probe for the research of pain and itch .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1173
CAS No.: 464-49-3
Synonyms: D-(+)-Camphor; (1R)-(+)-Camphor
(+)-Camphor (D-(+)-Camphor; (1R)-(+)-Camphor) is an isomer of Camphor. Camphor is an agonist of monoterpenoid transient receptor potential (TRP) channels (such as TRPV1, TRPV3, TRPM8) and an inhibitor of TRPA1 channels. Camphor's derivatives have multiple biological activities, including antibacterial, antiviral, antioxidant, analgesic and anticancer. Camphor can selectively activate cold-sensitive TRP channels and inhibit TRPA1-mediated nociceptive signals. Camphor stimulates the cold-sensing nerve endings in the skin and regulates the activity of ion channels to exert analgesic, anti-inflammatory and anti-itching effects. It also has anti-proliferative and anti-mutagenic activities on tumor cells, which may be related to inhibiting ribosome function or inducing cell apoptosis. Camphor can be absorbed through the skin and (+)-Camphor can be used in the study of muscle and joint pain and inflammation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148244
Purity:  99.88%
Research Areas:  

Others

MS47134 is a potent and selective MRGPRX4 agonist with an EC50 value of 149 nM. MS47134 can be used for research of pain, itch and mast cell-mediated hypersensitivity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145997
CAS No.: 2492596-61-7
Purity:  99.09%
MRGPRX4 modulator-1 (compound 31-2) is a potent mas-related g-protein receptor X4 (MRGPR X4) modulator, with antagonist activity of IC50 < 100 nM for MRGPR4. MRGPRX4 modulator-1 can be used for researching MRGPR X4 dependent diseases such as itch, pain, and autoimmune disorders .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-A0075
CAS No.: 13073-96-6
Synonyms: UCB 1402 dihydrochloride; NSC289116 dihydrochloride
Research Areas:  

Inflammation/Immunology

Decloxizine (UCB-1402; NSC289116) dihydrochloride is an orally active bronchodilator that can penetrate the blood-brain barrier. Decloxizine dihydrochloride is a piperazine-type H1 histamine receptor antagonist. Decloxizine dihydrochloride selectively blocks H1 histamine receptors, inhibiting histamine-induced capillary dilation, edema, and itching. Decloxizine dihydrochloride has some 5-HT2 receptor antagonistic activity. Decloxizine dihydrochloride can be used in studies of urticaria, allergic rhinitis, and bronchial asthma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-17582
CAS No.: 3733-63-9
Synonyms: UCB-1402; NSC289116
Research Areas:  

Inflammation/Immunology

Decloxizine (UCB-1402; NSC289116) is an orally active bronchodilator that can penetrate the blood-brain barrier. Decloxizine is a piperazine-type H1 histamine receptor antagonist. Decloxizine selectively blocks H1 histamine receptors, inhibiting histamine-induced capillary dilation, edema, and itching. Decloxizine has some 5-HT2 receptor antagonistic activity. Decloxizine can be used in studies of urticaria, allergic rhinitis, and bronchial asthma .
loading...
    loading...
Cat. No.: HY-P99162
CAS No.: 1476039-58-3
Synonyms: CIM331; CD14152

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Nemolizumab (CIM331) is a humanized monoclonal antibody that targets the human interleukin-31 receptor a, preventing interleukin-31 (IL-31) from binding to its receptor and the subsequent signaling. Nemolizumab can help reduce itching and sleep disturbances, and it is being studied for atopic dermatitis (AD) .
loading...
    loading...
Cat. No.: HY-165559
CAS No.: 2019994-90-0
Target:  

TRP Channel

Research Areas:  

Inflammation/Immunology

Trpvicin is a potent and subtype-selective TRPV3 inhibitor with IC50s of 0.41 and 0.22 μM for hTRPV3-WT and hTRPV3-G573S mutant, respectively. Trpvicin exhibits minimal effects on other TRP family members (such as TRPV1/2/4/5/6, TRPA1 and TRPM8). Trpvicin inhibits the TRPV3 channel by stabilizing it in a closed state via VSLD-PD binding. Trpvicin accesses additional binding sites inside the central cavity of the G573S mutant to remodel symmetry and block the channel. Trpvicin inhibits itch and hair loss in mouse models. Trpvicin can be used for study of inflammation and immunology .
loading...
    loading...
Cat. No.: HY-148949
CAS No.: 2361160-57-6
Purity:  98.96%
Target:  

Kallikrein

Research Areas:  

Others

Kallikrein 5-IN-2 (compound 21) is a selective Kallikrein KLK5 inhibitor (pIC50=7.1). KLK5 inhibition may normalise epidermal shedding and reduce the associated inflammation and itching .
loading...
    loading...
Cat. No.: HY-143481
CAS No.: 2756250-30-1
Nav1.8-IN-2 (compound 35A) is a Nav1.8 voltage-gated sodium ion inhibitor with an IC50 of 0.4 nM (HEK 293 cells). Nav1.8-IN-2 inhibits the activity of Nav1.8 voltage-gated sodium ion channels, mediates sodium ion influx in excitable cells, and is associated with the initiation and conduction of action potentials. Nav1.8-IN-2 can be used for research related to pain, cough, itching, etc .
loading...
    loading...
Cat. No.: HY-P3445
CAS No.: 2269511-95-5
Synonyms: HSK21542
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Anrikefon is a peripherally restricted kappa opioid receptor (KOR) agonist, with an IC50 of 0.54 nM, an EC50 of 2.41 pM, and a Ka of 0.068 nM against human KOR, and it exhibits high selectivity over μ and δ opioid receptors. Anrikefon exerts analgesic effects by inhibiting behaviors associated with inflammatory, postoperative and neuropathic pain, and also exerts antipruritic effects by reducing itch-related behaviors. Anrikefon can be used in research on pain, pruritus, and pruritus associated with chronic kidney disease .
loading...
    loading...
Cat. No.: HY-147051
CAS No.: 2492595-24-9
Purity:  99.94%
Synonyms: MRGPRX4 modulator-2
MRGPRX4 modulator-2 (compound 1-55) is a potent MRGPR X4 modulator, possessing antagonist activity against MRGPR X4 with an IC50 < 100 nM. MRGPRX4 modulator-2 can be used for researching autoimmune diseases such as psoriasis, multiple sclerosis, Steven Johnson’s Syndrome, and other chronic itch conditions .
loading...
    loading...
Cat. No.: HY-171366
CAS No.: 2458115-78-9
Target:  

JAK

Research Areas:  

Inflammation/Immunology

lirucitinib is a JAK inhibitor, and has antiinflammatory activity. lirucitinib inhibits various itch- and inflammation-inducing cytokines that depend on JAK1 enzyme activity, as well as allergy-related cytokines. lirucitinib can be used for the study of pruritic skin diseases
loading...
    loading...
Cat. No.: HY-145153
CAS No.: 885496-53-7
Purity:  98.83%
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

S-777469 is a selective and orally available cannabinoid type 2 receptor (CB2) agonist with a Ki of 36 nM. S-777469 significantly suppresses compound 48/80-induced scratching behavior in mice in a dose-dependent manner. S-777469 produces its antipruritic effects by inhibiting itch signal transmission through CB2 agonism .
loading...
    loading...
Cat. No.: HY-106566
CAS No.: 66734-13-2
Synonyms: Sch 22219
Research Areas:  

Inflammation/Immunology

Alclometasone dipropionate (Sch 22219) is a steroid compound. Alclometasone dipropionate can be used for the research of dermatitis and skin itch .
loading...
    loading...
Cat. No.: HY-135495
CAS No.: 1642113-59-4
AM-0466 is a sodium channel inhibitor with nanomolar levels of NaV1.7 inhibitory activity. AM-0466 exhibits potent pharmacodynamic activity in a NaV1.7-dependent histamine-induced itch model. AM-0466 also showed significant analgesic effects in capsaicin-induced pain models. After optimizing its pharmacokinetic properties, AM-0466 was advanced into in vivo targeting and efficacy models for testing .
loading...
    loading...
Cat. No.: HY-163840
Target:  

GDNF Receptor

Research Areas:  

Neurological Disease

GFRα2/3-IN-1 (Compound 16) is a selective GFRα2/3 inhibitor with IC50 values of 0.1 and 0.2 μM for GFRα2 and GFRα3, respectively. GFRα2 is a glial cell line-derived neurotrophic factor (GDNF) receptor related to GFRα1, GFRα2/3-IN-1 can be used for pain and itch research .
loading...
    loading...